Topic

Physics

The rules underneath, as far as they are known.

4: in business
10:16: average
41 min: in total
206: across the network

Physics across the network →

All briefs4

10:03

Sanofi

Sanofi-Aventis wasn’t built to invent new medicines — it was built to own the ones that already paid.

9:46

Bristol Myers Squibb

A 1989 merger of two penicillin-makers became a US-revenue monoculture built on seven drugs — not science, but scale.

9:24

Genmab is a platform biotech — not a drug developer — built around two licensed and proprietary antibody generation methods. Its value is in reducing discovery risk and time, not in owning clinical or commercial outcomes.

11:49

Boehringer Ingelheim

Albert Boehringer · 1885

Boehringer Ingelheim is a rare case of sustained private ownership enabling both technical continuity (from lactic acid to biopharma) and social infrastructure (welfare policies pre-dating national systems). Its business model is not about disruption but compound discipline: owning the science, the scale, and the staff.